Zobrazeno 1 - 1
of 1
pro vyhledávání: '"D. Falleroni"'
Publikováno v:
Annals of the Rheumatic Diseases. 80:67-67
Background:VIB4920 binds CD40 ligand and functionally neutralizes its engagement with CD401. We reported results through Day 85 of a Phase 1b, randomized, double-blind, placebo-controlled study (NCT02780388) in subjects with moderate to severe rheuma